Emergent Biosolutions (NYSE: EBS) revenue
Emergent Biosolutions reported revenue of $742.9m for fiscal 2025, 28.8% less than in fiscal 2024 ($1,044m). Since fiscal 2016 its revenue has grown by 52.0%, an average growth of 4.8% a year.
Emergent Biosolutions's revenue has fallen for 4 years in a row, and its best year of the last 10 was fiscal 2021. The biggest drop was in fiscal 2022, −37.0%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $742.9m | −28.8% | $100.1m | 13.5% |
| 2024 | $1,044m | −0.5% | −$108.7m | −10.4% |
| 2023 | $1,049m | −6.1% | −$726.4m | −69.2% |
| 2022 | $1,118m | −37.0% | −$170.0m | −15.2% |
| 2021 | $1,774m | +12.4% | $341.4m | 19.2% |
| 2020 | $1,577m | +42.6% | $438.5m | 27.8% |
| 2019 | $1,106m | +41.4% | $114.1m | 10.3% |
| 2018 | $782.4m | +39.5% | $89.8m | 11.5% |
| 2017 | $560.9m | +14.8% | $124.3m | 22.2% |
| 2016 | $488.8m | — | $105.5m | 21.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Emergent Biosolutions revenue compared with its sector
By revenue for its latest fiscal year, Emergent Biosolutions ranks 172nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Emergent Biosolutions, −28.8%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 170th | Alphatec | $764.2m | 25.0% |
| 171st | iRhythm | $747.1m | 26.2% |
| 172nd | Emergent Biosolutions | $742.9m | −28.8% |
| 173rd | Repligen | $738.3m | 16.4% |
| 174th | NeoGenomics | $727.3m | 10.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Emergent Biosolutions
- How much revenue did Emergent Biosolutions make in fiscal 2025?
- Emergent Biosolutions reported revenue of $742.9m for fiscal 2025, compared with $1,044m in fiscal 2024.
- How much has the revenue of Emergent Biosolutions grown?
- Between fiscal 2016 and fiscal 2025 it went from $488.8m to $742.9m: 52.0% more, an average growth of 4.8% a year.
- What was the best year for revenue at Emergent Biosolutions?
- Of its last 10 fiscal years, fiscal 2021, with $1,774m.
- Where does Emergent Biosolutions rank in its sector by revenue?
- It ranks 172nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Emergent Biosolutions come from?
- From the annual report (Form 10-K) that Emergent Biosolutions files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Emergent Biosolutions files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Emergent Biosolutions: the Emergent Biosolutions page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.